Yumanity Therapeutics (YMTX) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free YMTX Stock Alerts $0.63 +0.11 (+20.96%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJSPR Jasper Therapeutics, Inc.seekingalpha.com - March 20 at 7:11 PMCara Therapeutics Inc CARAmorningstar.com - November 3 at 7:42 AMYumanity Therapeutics Inc.thestreet.com - October 6 at 6:24 PMFormer Onyx CEO Returns to Biotech to Launch Boston Start Upthestreet.com - July 5 at 1:02 AMKineta raises $6M through registered direct offeringbizjournals.com - May 1 at 1:51 AMColorectal Cancer Therapeutics Market Size to Surpass US$ 24.58 Billion by 2030 - Growth Plus Reportsfinance.yahoo.com - February 22 at 10:00 AMYumanity Therapeutics's Return On Capital Employed Insightsmsn.com - December 26 at 1:21 PMKineta finalizes reverse merger with Yumanity, secures additional fundingbizjournals.com - December 20 at 6:58 PMYumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kinetafinance.yahoo.com - December 5 at 6:26 PMWhy Is Yumanity Therapeutics (YMTX) Stock Up Today?investorplace.com - December 5 at 3:03 PMYumanity Therapeutics Inc: Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developmentsfinanznachrichten.de - November 14 at 11:42 AMYumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developmentsfinance.yahoo.com - November 14 at 11:42 AMYumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.finance.yahoo.com - November 10 at 4:45 PMYumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kinetafinance.yahoo.com - August 29 at 10:16 AMYumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developmentsfinance.yahoo.com - August 4 at 6:52 PMInside Kineta's plans after unveiling reverse merger dealfinance.yahoo.com - June 8 at 9:39 PMSeattle biotech Kineta to go public in merger deal with Yumanity Therapeuticsbizjournals.com - June 7 at 11:47 PMShort Volatility Alert: Yumanity Therapeutics, Inc.msn.com - June 7 at 6:47 PMYumanity to Sell Neurosciences Candidates, Merge With Kineta >YMTXmarketwatch.com - June 6 at 12:23 PMYumanity stock soars 46% on all-stock merger with Kineta; lead product sale to J&J for $26Mseekingalpha.com - June 6 at 12:23 PMYumanity Therapeutics To Sell 2 Product Candidates For $26 Mln In Cash; Inks Merger Deal With Kinetanasdaq.com - June 6 at 12:23 PMYumanity Therapeutics Shares Trading Higher Today - Read Here Whyfinance.yahoo.com - June 6 at 12:23 PMWhy Is Yumanity Therapeutics (YMTX) Stock Up 50% Today?investorplace.com - June 6 at 10:13 AMYumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactionsfinance.yahoo.com - June 6 at 7:23 AM53 Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com - June 2 at 12:32 PMYumanity Therapeutics GAAP EPS of -$1.24, revenue of $1.02Mseekingalpha.com - May 14 at 9:53 PMYumanity Therapeutics (YMTX) Reports Q1 Loss, Misses Revenue Estimatesfinance.yahoo.com - May 13 at 1:51 AMYumanity Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Developmentsfinance.yahoo.com - May 13 at 1:51 AMLooking Into Yumanity Therapeutics's Return On Capital Employedbenzinga.com - March 25 at 3:34 PMYumanity Therapeutics GAAP EPS of -$3.84, revenue of $8.04Mseekingalpha.com - March 24 at 6:43 PMYumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Developmentsfinance.yahoo.com - March 24 at 6:43 PMYumanity to cut 60% of workforce as it evaluates strategic alternativesseekingalpha.com - February 17 at 12:52 PMYumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuringfinance.yahoo.com - February 17 at 12:52 PMmarketbeat.com - February 17 at 8:28 AMYumanity Says FDA Puts Partial Hold on YTX-7739 Studies >YMTXmarketwatch.com - January 19 at 6:36 PMYumanity Therapeutics Shares Tumble on Partial FDA Study Hold >YMTXmarketwatch.com - January 19 at 6:36 PMYumanity's multi-dose clinical trial put on hold by FDA, stock slides 12%seekingalpha.com - January 19 at 1:36 PMYumanity Shares Fall On FDA Hold On Multidose Trials In Parkinson's Diseasemsn.com - January 19 at 1:36 PMYumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739finance.yahoo.com - January 19 at 8:36 AMYumanity Therapeutics (NASDAQ:YMTX) Upgraded to "Buy" by Zacks Investment Researchmarketbeat.com - January 18 at 12:37 PMYumanity’s Approach to Neurodegenerative Diseases Validated by Two External Collaborationsfinance.yahoo.com - January 11 at 8:17 AMYumanity Therapeutics, Inc. (NASDAQ:YMTX) Short Interest Down 61.4% in Decembermarketbeat.com - January 5 at 1:34 AMYumanity Therapeutics to Present at the H.C. Wainwright BioConnect Conferencefinance.yahoo.com - January 4 at 8:59 AMYumanity Therapeutics, Inc. (YMTX)realmoney.thestreet.com - December 31 at 12:33 AMYumanity Therapeutics Inc Shares Fall 0.7% Below Previous 52-Week Low - Market Movernasdaq.com - December 29 at 8:49 AMYumanity Therapeutics to Present at Multiple Upcoming November Investor Conferencesfinance.yahoo.com - November 16 at 5:57 PMYumanity: Q3 Earnings Snapshotchron.com - November 15 at 12:50 PMYumanity Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Developmentsfinance.yahoo.com - November 15 at 7:50 AMMid-afternoon market update: Nasdaq tumbles 300 points, Pubmatic shares gain after Q3 resultsfxstreet.com - November 12 at 10:19 AMYumanity Therapeutics Stock Plunges After Parkinson's Trial Datafinance.yahoo.com - November 11 at 12:53 AM Get Yumanity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for YMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here YMTX Media Mentions By Week YMTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. YMTX News Sentiment▼0.000.47▲Average Medical News Sentiment YMTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. YMTX Articles This Week▼00▲YMTX Articles Average Week Get Yumanity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for YMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lumos Pharma News Onconova Therapeutics News Vincerx Pharma News Synlogic News MEI Pharma News FSD Pharma News BioVie News Flora Growth News RenovoRx News Cumberland Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:YMTX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yumanity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
